Navigation Links
Antipsychotic Drugs Linked to Higher Odds for Diabetes in Pregnancy
Date:7/2/2012

MONDAY, July 2 (HealthDay News) -- New research suggests pregnant mothers who take certain antipsychotic drugs may face a higher risk of gestational diabetes, which can appear during pregnancy.

Gestational diabetes involves high blood sugar that starts or is first diagnosed during pregnancy. According to the U.S. National Institutes of Health, gestational diabetes can pose hazards for both mother and baby.

The new study appears in the July issue of the journal Archives of General Psychiatry.

The drugs on which the study focused are used to treat severe mental illnesses such as schizophrenia and bipolar disorder.

Until now, "the evidence concerning use of antipsychotics during pregnancy [was] generally lacking or weak," the authors of the new study, led by Dr. Robert Boden of Karolinska Institutet and Uppsala University, both in Sweden, noted in a journal news release.

The researchers studied medical records of Swedish people, focusing on hundreds of thousands of women who gave birth between July 2005 and December 2009.

Gestational diabetes was more than twice as common (4.3 percent vs. 1.7 percent) in women who filled prescriptions for antipsychotics, the researchers reported. The study did not, however, prove the antipsychotics directly increased the risk of gestational diabetes.

"Maternal use of antipsychotics during pregnancy ... is associated with an increased risk of gestational diabetes," the authors wrote. "Pregnant women treated with antipsychotics should be closely monitored for gestational diabetes and deviating fetal growth."

One expert in the United States agreed that there has been "a paucity of information" about potential links between these drugs and diabetes in pregnancy.

"However, this study and others recently have suggested that the use of antipsychotics during pregnancy is not as free of risk as traditionally thought," said Dr. Bryan Bruno, acting chairman of the department of psychiatry at Lenox Hill Hospital in New York City.

"The peak age of onset of schizophrenia in women is 25 to 35 years old, which are also the peak childbearing years," he said. "Women with psychotic illnesses are likely to have more unplanned pregnancies than women without a psychotic illness."

"Obviously, if a patient can do without the medication, it would be appropriate to discontinue it," Bruno said. "But this is frequently not the case, and these decisions have to be made on a case-by-case basis weighing the relative risks versus benefits."

"With limited research data on the impact of newer atypical antipsychotics during pregnancy, pregnant women with bipolar disorder or schizophrenia may be better off with the older antipsychotics," he added. He said the reproductive-safety data on older antipsychotics is more robust and reassuring than it is for newer drugs.

More information

For more on pregnancy, head to the U.S. National Library of Medicine.

-- Randy Dotinga

SOURCES: Bryan Bruno, M.D., acting chairman, department of psychiatry, Lenox Hill Hospital, New York City; July 2, 2012, news release, Archives of General Psychiatry


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Reducing off-label use of antipsychotic medications may save money
2. Antipsychotics Do Help Many With Schizophrenia, Study Finds
3. As New Premature Ejaculation Drugs Get Closer To The Public Market, LastLonger2Night.com Announces A Drug-Free Solution
4. Epilepsy drugs increase risk of fractures and falls
5. 40 Million Americans Addicted to Cigarettes, Alcohol or Drugs
6. Intensive cholesterol therapy with multiple drugs effective over long term
7. The US Drug Watchdog Now Urges Plaintiffs Law Firms Worldwide To Contact Them About A Possible International Effort To Help Victims Of Defective Drugs Or Medical Devices
8. Herpes Treatment Site: Top Reasons to Avoid Prescription HSV Drugs
9. Metformin Outperforms Common Class of Diabetes Drugs in Study
10. Could Fertility Drugs Make Kids Shorter?
11. Enzyme offers new therapeutic target for cancer drugs
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Antipsychotic Drugs Linked to Higher Odds for Diabetes in Pregnancy
(Date:4/28/2017)... ... ... The Radiology Business Management Association (RBMA) is pleased to announce ... process has been in place since the RBMA was founded in 1968 with all ... Jim Hamilton, MHA, CMM, FRBMA, as president. Dr. Dickerson the chief executive officer for ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... and College of Urgent Care Medicine will host industry leaders for the annual ... will help those in the industry adapt to the issues currently affecting urgent ...
(Date:4/28/2017)... ... , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh in Abilene, Texas, has ... which He does not. Yisrayl says with so many titles and names for the ... he says with a little Scripture, backed with a lot of research, the truth is ...
(Date:4/28/2017)... (PRWEB) , ... April 28, 2017 , ... ... skincare and advanced nutraceutical supplements, through its Nova Skin Sciences division, recently ... hydrating benefits of a moisturizer with the power of an anti-aging concentrate. ...
(Date:4/28/2017)... ... 2017 , ... Christie Medical Holdings, Inc. , with its market-leading ... Medical Inc. , a leader in infusion therapy and pain management. , Intravenous ... percent of hospital patients receiving a peripheral IV catheter as part of their treatment ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... , Tenn. and DALLAS , April 19, ... Inc., announced that the first patients in ... EndoStim device in the Lower Esophageal Sphincter Stimulation for ... minimally-invasive implantable device designed to provide long-term reflux control ... GERD affects nearly 65 million people in ...
(Date:4/19/2017)... , April 19, 2017  Novartis today announced ... National Heart, Lung, and Blood Institute (NHLBI) of ... 58% of patients with treatment-na├»ve severe aplastic anemia ... treated with eltrombopag at the initiation of and ... study evaluated three sequential treatment groups, or cohorts. ...
(Date:4/18/2017)... 18, 2017 Research and Markets has announced ... report to their offering. ... global arthroscopy devices market to grow at a CAGR of 6.35% ... Devices Market 2017-2021, has been prepared based on an in-depth market ... landscape and its growth prospects over the coming years. The report ...
Breaking Medicine Technology: